Karikó K, Kuo A, Boyd D, Okada S S, Cines D B, Barnathan E S
Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia 19104.
Cancer Res. 1993 Jul 1;53(13):3109-17.
Proteolysis triggered by receptor-bound urokinase-type plasminogen activator (uPA) involves a cascade of species-specific molecular interactions. To study the role of the uPA receptor (uPAR) in such interactions, a human osteosarcoma cell line (HOS), which normally expresses low levels of uPAR, was transfected with human uPAR complementary DNA. One of several stably transformed clonal cells lines, designated 2A2, was characterized and compared to the parental HOS, revealing the following: (a) stable incorporation of uPAR complementary DNA into the genome demonstrated by Southern blot analysis; (b) a 10-fold increase in steady state mRNA levels of uPAR assessed by Northern blot analysis; (c) a 2-fold increase in the surface expression of glycosylphosphatidylinositol anchored uPAR protein determined by enzyme-linked immunosorbent assay and by the specific binding of radiolabeled single chain uPA; (d) a 2-fold increase in internalization and degradation of radiolabeled uPA/PAI-1 complexes; and (e) a 2-fold increase in receptor-bound uPA-mediated plasmin generation measured by the cleavage of a chromogenic substrate and degradation of 125I-labeled laminin. The involvement of uPAR in cellular processes was determined by comparing 2A2 and HOS cells in in vitro migration and invasion assays. The migration of 2A2 cells were slower on fibronectin-coated surfaces in a linear under-agarose assay, but both cell lines migrated at the same rate on uncoated polycarbonate filters in Boyden chamber assays. In the invasion experiments, 4 times more 2A2 than HOS cells penetrated through the barrier of reconstituted basement membrane Matrigel. These data suggest that uPAR does not potentiate random cell migration but facilitates matrix degradation and subsequent cell invasion.
受体结合型尿激酶型纤溶酶原激活剂(uPA)引发的蛋白水解涉及一系列物种特异性分子相互作用。为了研究uPA受体(uPAR)在此类相互作用中的作用,将通常低水平表达uPAR的人骨肉瘤细胞系(HOS)用人类uPAR互补DNA进行转染。几个稳定转化的克隆细胞系之一,命名为2A2,进行了特性鉴定并与亲本HOS进行比较,结果如下:(a)通过Southern印迹分析证明uPAR互补DNA稳定整合到基因组中;(b)通过Northern印迹分析评估uPAR的稳态mRNA水平增加了10倍;(c)通过酶联免疫吸附测定法以及放射性标记的单链uPA的特异性结合确定,糖基磷脂酰肌醇锚定的uPAR蛋白的表面表达增加了2倍;(d)放射性标记的uPA/PAI-1复合物的内化和降解增加了2倍;(e)通过显色底物的裂解和125I标记的层粘连蛋白的降解测定,受体结合的uPA介导的纤溶酶生成增加了2倍。通过在体外迁移和侵袭试验中比较2A2和HOS细胞来确定uPAR在细胞过程中的参与情况。在直线型琼脂糖下试验中,2A2细胞在纤连蛋白包被的表面上迁移较慢,但在Boyden小室试验中,两种细胞系在未包被的聚碳酸酯滤膜上以相同速率迁移。在侵袭实验中,穿透重组基底膜基质胶屏障的2A2细胞比HOS细胞多4倍。这些数据表明,uPAR不会增强随机细胞迁移,但会促进基质降解和随后的细胞侵袭。